These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2729330)

  • 1. Intrathecal cytosine arabinoside-induced acute, rapidly reversible paralysis.
    Saleh MN; Christian ES; Diamond BR
    Am J Med; 1989 Jun; 86(6 Pt 1):729-30. PubMed ID: 2729330
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia.
    von der Weid NX; de Crousaz H; Beck D; Deonna T; Miklossy J; Janzer RC
    Med Pediatr Oncol; 1991; 19(3):192-8. PubMed ID: 2023567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraplegia following intrathecal cytosine arabinoside.
    Wolff L; Zighelboim J; Gale RP
    Cancer; 1979 Jan; 43(1):83-5. PubMed ID: 282937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of cerebral spinal fluid replacement on acute myelopathy induced by intrathecal therapy of leukemia.
    Wang Z; Xu W; Liu L; Ding Z
    Leuk Res; 2011 Jun; 35(6):e79-80. PubMed ID: 21247632
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukemia of B-cell type.
    Resar LM; Phillips PC; Kastan MB; Leventhal BG; Bowman PW; Civin CI
    Cancer; 1993 Jan; 71(1):117-23. PubMed ID: 8416707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophthalmoparesis due to Burkitt's lymphoma following cardiac transplantation.
    Liu GT; Kay MD; Byrne GE; Glaser JS; Schatz N
    Neurology; 1993 Oct; 43(10):2147-9. PubMed ID: 8413988
    [No Abstract]   [Full Text] [Related]  

  • 7. Paraparesis following intrathecal chemotherapy.
    Hahn AF; Feasby TE; Gilbert JJ
    Neurology; 1983 Aug; 33(8):1032-8. PubMed ID: 6688295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute encephalopathy and cerebral vasospasm after multiagent chemotherapy including PEG-asparaginase and intrathecal cytarabine for the treatment of acute lymphoblastic leukemia.
    Pound CM; Keene DL; Udjus K; Humphreys P; Johnston DL
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):183-6. PubMed ID: 17356399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal cytarabine in cerebrospinal fluid.
    Boyd K; Jenner M; Treleaven J; Kenny J; Rhoades E
    Br J Haematol; 2009 Jun; 145(6):679. PubMed ID: 19076172
    [No Abstract]   [Full Text] [Related]  

  • 10. [Paraplegia following intrathecal chemotherapy].
    Beretta F; Sanna P; Ghielmini M; Marini G; Cavalli F
    Schweiz Med Wochenschr; 1996 Jun; 126(25):1107-11. PubMed ID: 8711459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive ascending paralysis following administration of intrathecal and intravenous cytosine arabinoside. A Pediatric Oncology Group study.
    Dunton SF; Nitschke R; Spruce WE; Bodensteiner J; Krous HF
    Cancer; 1986 Mar; 57(6):1083-8. PubMed ID: 3455842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal chemotherapy in Burkitt's lymphoma.
    Ziegler JL; Bluming AZ
    Br Med J; 1971 Aug; 3(5773):508-12. PubMed ID: 5109411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma.
    Corazzelli G; Frigeri F; Russo F; Frairia C; Arcamone M; Esposito G; De Chiara A; Morelli E; Capobianco G; Becchimanzi C; Volzone F; Saggese M; Marcacci G; De Filippi R; Vitolo U; Pinto A
    Br J Haematol; 2012 Jan; 156(2):234-44. PubMed ID: 22098541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excessive spinal cord toxicity from intensive central nervous system-directed therapies.
    Watterson J; Toogood I; Nieder M; Morse M; Frierdich S; Lee Y; Moertel CL; Priest JR
    Cancer; 1994 Dec; 74(11):3034-41. PubMed ID: 7954266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute reversible neurological deficit following intrathecal chemotherapy.
    Dunkelman H; Earl HM; Twelves C
    Cancer Chemother Pharmacol; 1991; 27(4):329-30. PubMed ID: 1998991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of a patient with seropositive human immunodeficiency virus with high risk Burkitt's leukemia.
    Greenberg AL; Droller DG
    Cancer; 1994 Aug; 74(4):1261-4. PubMed ID: 8055447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraplegia following intrathecal chemotherapy.
    Saiki JH; Thompson S; Smith F; Atkinson R
    Cancer; 1972 Feb; 29(2):370-4. PubMed ID: 4552135
    [No Abstract]   [Full Text] [Related]  

  • 18. Percutaneous lumbar intrathecal catheter for the administration of chemotherapy.
    Tobias JD; Oakes L; Foreman NK; Mahmoud H
    Med Pediatr Oncol; 1991; 19(4):301-3. PubMed ID: 2056974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible posterior leukoencephalopathy after combination chemotherapy.
    Honkaniemi J; Kähärä V; Dastidar P; Latvala M; Hietaharju A; Salonen T; Keskinen L; Ollikainen J; Vähämäki L; Kellokumpu-Lehtinen P; Frey H
    Neuroradiology; 2000 Dec; 42(12):895-9. PubMed ID: 11198208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose cytosine arabinoside therapy in acute non-lymphocytic leukemia.
    Preisler HD
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):297-300. PubMed ID: 6538493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.